Survival and Quality of Life for Nonagenarians After Cardiac Surgery
|
|
- Abel Greer
- 5 years ago
- Views:
Transcription
1 Survival and Quality of Life for Nonagenarians After Cardiac Surgery Manuel Caceres, MD, Wen Cheng, MD, Michele De Robertis, RN, James M. Mirocha, MS, Lawrence Czer, MD, Fardad Esmailian, MD, Ali Khoynezhad, MD, Danny Ramzy, MD, Robert Kass, MD, and Alfredo Trento, MD Divisions of Cardiothoracic Surgery, Cedars Sinai Heart Institute, Cedars Sinai Medical Center, Los Angeles, California; and Divisions of Cardiothoracic Surgery, Veterans Affairs Medical Center, Memphis, Tennessee Background. Reports of cardiac surgery in the elderly have focused primarily on septuagenarians and octogenarians. There are very limited data regarding riskadjusted models in nonagenarians. Methods. From 1983 to 211, patients with age 9 years or greater at the time of coronary artery bypass grafting (CABG) or valve surgery (aortic or mitral) were retrieved from a prospective institutional database. A Cox proportional hazard model was used to determine significant predictors of 5-year survival. In addition, a 12-month assessment of quality of life was conducted. Results. The CABG-only (n [ 46), valve-only (n [ 55), or CABG-valve (n [ 53) surgery was conducted in 154 patients. Demographic characteristics were similar in all groups except for congestive heart failure, which was more prominent in the valve-only or CABG-valve groups (p <.1). The 3-day mortality was 8.8%, 12.8%, and 18.9% in the CABG-only, valve-only, and CABG-valve groups, respectively, without significant difference among groups (p [.35). At 5-years followup, the Kaplan-Meier survival curves do not show a difference among groups (p [.62). Cox proportional hazard model for 5-year survival identified age (hazard ratio [HR] [ 1.25, confidence interval [CI] 1.9 to 1.43, p [.1, for 1-year increase), prior surgery (HR [ 2.23, CI 1.23 to 4.64, p [.7), and prior stroke (HR [ 2.39, CI 1.25 to 3.98, p [.1), as significant predictors of mortality. The 12-month quality of life questionnaire revealed an improvement in 83% of the patients, whereas only 4% reported a decline in cardiac status. Conclusions. Survival in nonagenarians is comparable after CABG or valve surgery. Redo surgery, stroke, and increasing age are significant hazards for mortality. Nonagenarians can undergo cardiac surgery with acceptable mortality and quality of life. (Ann Thorac Surg 213;95: ) Ó 213 by The Society of Thoracic Surgeons Life expectancy in the western world has continued to increase, creating a challenging demand in healthcare systems for future decades. As per the latest national projections in the United States, the population older than 85 years of age accounted for 5.7 million in 21, and by 25 it is projected to surpass 19 million [1]. Furthermore, there is evidence of a higher prevalence of cardiovascular disease with advanced age [2, 3]; thus, the cardiac surgeon is likely to be challenged by an increasing volume of elderly patients in need of heart surgery evaluation. Publications describing risk stratification and outcomes of cardiac surgery in the elderly have primarily focused on septuagenarians and octogenarians, and report favorable results in survival and quality of life [4 7]. Cardiac surgery in nonagenarians has been reported sparsely and has been largely limited to small patient samples not suitable to conduct meaningful risk stratification analyses; yet, it has rapidly increased in the last 2 decades. Furthermore, the majority of studies have Accepted for publication Feb 25, 213. Address correspondence to Dr Caceres, 13 Jefferson Ave, Memphis, TN 3814; caceres manuel@hotmail.com. focused on operative survival with limited information on long-term results and quality of life. With the progressive expansion of the elderly population and the current landscape of cost containment in healthcare, it is essential to analyze the role of cardiac surgery in this growing sector of the population. We present the largest single-center experience of cardiac surgery in nonagenarians, reporting outcomes of early- and long-term survival, and quality of life. Furthermore, a multivariable analysis is performed to identify predictors associated with long-term survival. Patients and Methods Study Population The Cardiothoracic Surgery Quality Assurance Database at the Cedars Sinai Medical Center, Los Angeles, California, was queried to identify all patients 9 years of age or older who underwent open-heart surgery from 1983 to 211. Three surgical categories were defined as the following: isolated coronary artery bypass graft (CABGonly); isolated aortic or mitral valve repair or replacement (valve-only), and combined CABG with aortic or mitral valve repair or replacement (CABG-valve). All patients Ó 213 by The Society of Thoracic Surgeons 3 49/$36. Published by Elsevier Inc
2 Ann Thorac Surg CACERES ET AL 213;95: SURVIVAL AND QOL FOR NONAGENARIANS AFTER CARDIAC SURGERY were prospectively followed and a quality of life (QOL) assessment was conducted at 12 months. Operative mortality was defined as death within 3 days, and survivors were followed until death or the end of the study through telephone interviews, clinic appointments, or contact with the primary care providers. In addition, the Social Security Death Index was queried to determine the survival status of patients not identified through the established institutional follow-up protocol. Approval to conduct this outcomes review was obtained by our Institutional Review Board. Statistical Analysis Patient characteristics were recorded for each of the 3 surgical categories. Continuous variables were presented as the mean standard deviation (SD), and compared using the nonparametric Kruskal-Wallis test or analysis of variance, as appropriate. Categoric variables were presented as percentages and compared using the c 2 test or the Fisher exact test, as appropriate. Kaplan Meier survival curves and median survivals are presented for each surgical category and compared with the log-rank test. Likewise, survival curves are presented for septuagenarians and octogenarians undergoing CABG-only, valve-only, or CABG-valve during the time frame of the study, and compared with nonagenarians. The following preoperative variables were initially selected to develop a multivariable risk model of 5-year survival based on Cox proportional hazards regression: Age, gender, diabetes, hypertension, renal insufficiency (defined as creatinine > 1.5 mg/dl), history of cerebrovascular accident (CVA), congestive heart failure (CHF), ejection fraction (EF), prior surgery, and type of surgery (CABG-only, valve-only, CABG-valve; valve-only served as the reference group). An analysis of the effects eligible for entry in the risk model was conducted with each of the selected preoperative variables and a forward stepwise selection method was used to select the variables independently associated with 5-year survival. Although an objective assessment of the frailty of each patient was not prospectively recorded, the CHF functional class (1 to 4) was used as a surrogate of preoperative functional assessment. To provide a more accurate estimate of renal function, the glomerular filtration rate (GFR) was calculated using the Modification of Diet in Renal Disease (MDRD) formula, and a GFR value lower than 6 was used to identify renal dysfunction. The multivariable risk model was recalculated using this definition. Variables with a p value less than.5 were retained in the final model. The proportional hazards assumption was checked using the supremum test. Statistical calculations were conducted by using SAS version 9.2 (SAS Institute, Cary, NC). Results 1599 From 1983 to 211, a total of 154 patients 9 years of age or greater underwent open-heart surgery. The mean age was 91.4 years (range, 9 to 97 years), 4.9% (63 of 154) were women, the mean EF was.518 (interquartile range [IQR] 4.% to 6.1%), 11.7% (18 of 154) had diabetes, 19.5% (3 of 154) had renal insufficiency (creatinine > 1.5 mg/dl), 62.3% (96 of 154) had hypertension, 62.3% (96 of 154) had CHF, 9.1% (14 of 154) had a history of CVA, and 14.9% (23 of 154) had a history of prior sternotomy. The mean MDRD-calculated GFR was The breakdown according to surgery type was as follows: 29.9% (46 of 154) CABG-only; 34.4% (53 of 154) CABG-valve surgery (mitral or aortic valve); and 35.7% (55 of 154) valve-only surgery (mitral or aortic valve). Demographic characteristics were similar among the 3 surgery categories except for CHF, which was more prominent in the valve-only and CABGvalve groups. Patient characteristics by surgical category are shown in Table 1. The 3-day operative mortality was 13.6% (21 of 154); 8.8% (4 of 46) for CABG-only, 12.7% (7 of 55) for valveonly, and 18.9% (1 of 53) for CABG-valve. The log-rank test did not show a significant difference among surgery ADULT CARDIAC Table 1. Patient Characteristics by Surgery Type Characteristic CABG Only (n 46) CABG Valve (n 53) Valve Only (n 55) p Value Age (years), mean SD Male gender, n (%) 29 (63.) 33 (62.3) 29 (52.7).51 EF, mean SD Diabetes, n (%) 2 (4.4) 11 (2.8) 5/52 (9.6).39 Creatinine > 1.5, n (%) 9/43 (2.9) 11/52 (21.2) 12/52 (23.1) >.99 MDRD, mean HTN, n (%) 28 (6.9) 32 (6.4) 36/52 (69.2).9 CHF, n (%) 13/43 (3.2) 38/53 (71.7) 45/53 (84.9) <.1 CVA, n (%) 3/41 (7.3) 5/48 (1.4) 6/5 (12.).78 Prior surgery, n (%) 4/46 (8.7) 8/53 (15.1) 11/55 (2.).27 Valve replacement, n (%) >.99 Aortic 43 (81.1) 42/54 (77.8) Mitral 6 (11.3) 7/54 (13.) Aortic and mitral 4 (7.6) 5/54 (9.3) CABG ¼ coronary artery bypass grafting; CHF ¼ congestive heart failure; CVA ¼ cerebrovascular accident; EF ¼ ejection fraction; HTN ¼ hypertension; MDRD ¼ modification of diet in renal disease.
3 16 CACERES ET AL Ann Thorac Surg SURVIVAL AND QOL FOR NONAGENARIANS AFTER CARDIAC SURGERY 213;95: groups at 3 days (p ¼.35). The median follow-up was 2.7 [IQR:.6 5.3] years, and the 1- and 5-year survival rates were 71.8% and 37.1%, respectively. The median survival was 3.5 [IQR: ] years; 4.1 [IQR: ] years for the CABG-only group, 2.8 [IQR: ] years for the CABG-valve group, and 2.7 [IQR: ] years for the valve-only group. Kaplan-Meier survival curves were plotted for the 3 surgical groups, and the CABG-only group appears to carry a better survival for the first 4 years; however, the log-rank test failed to identify any significant difference at 5 years (p ¼.62, Fig 1) or 1 years (p ¼.88) of follow-up. Survival curves were also plotted for patients 7 years or older during the time frame of the study, and the median survivals were 8.9 years ([95% confidence interval [CI]: 8.7 to 9.2] for septuagenarians, 5.7 years [95% CI: 5.4 to 6.] for octogenarians, and 3.5 years [95% CI: 2.6 to 4.3] for nonagenarians, showing a significant difference among groups (p <.1). Survival curves are shown in Figures 1 and 2. Living arrangement prior to surgery was; 64.5% (98 of 152) lived at home with a spouse or friend, 28.9% (44 of 152) lived alone, and 6.6% (1 of 152) lived in a board and care facility. At discharge, 35.3% (53 of 15) were released to home, 5.3% (8 of 15) to friends or relatives, 2% (3 of 15) to a board and care facility, and 39.3% (59 of 15) to extended care facilities. A risk model, based on Cox proportional hazards regression, was developed to identify the variables associated with 5-year survival. The univariate assessment through an analysis of effect of eligibility for each candidate variable revealed age (p ¼.7) to have the highest Wald c 2 value; thus, age was entered first in the stepwise selection process. After the testing of each variable in the model, age (p <.1), prior surgery (p ¼.6), and CVA (p ¼.1) were retained as significant predictors of a decreased 5-year survival. To better adjust for the significance of renal dysfunction, creatinine level was replaced by MDRD-calculated GFR; likewise, Percent Surv va Number at Risk CHF functional class was used as a surrogate of the frailty condition of the patients. Neither variable showed a significant association with survival. The results of the analysis of eligibility for each candidate variable and the multivariable analysis are shown in Tables 2 and 3. A QOL questionnaire was sent to all the survivors 1 year after surgery, with 71 responding of the 11 patients who were alive at the 1-year mark. The questionnaire revealed an improvement in 83% (59 of 71) of the respondents whereas only 4% (3 of 71) reported a decrease in their quality of life. Comment Septuagenarian Octogenarian Nonagenarian Log-Rank P <.1 Years Fig 2. Five year survival after open heart surgery; septuagenarians (blue), octogenarians (red), and nonagenarians (green) The present study reports the largest single-center experience of cardiac surgery in nonagenarians, presenting Percent Surv va Number at Risk CABG CABG + Valve Valve Only Log-Rank P =.62 Years Fig 1. Open heart surgery in nonagenarians: 5 year survival. (CABG coronary artery bypass grafting.) Table 2. Analysis of Eligibility of Candidate Variables Candidate Variable p Value Age.7 Gender: male.2 CABG valve vs valve only.66 CABG only vs valve only.61 Diabetes.42 Hypertension.137 Cerebrovascular accident.24 Creatinine > 1.5 mg/dl.39 MDRD < 6.1 Prior surgery.26 Ejection fraction.43 CHF NYHA 1 vs NYHA 4.56 CHF NYHA 2 vs NYHA 4.25 CHF NYHA 3 vs NYHA 4.41 CABG ¼ coronary artery bypass grafting; CHF ¼ congestive heart failure; MDRD ¼ modification of diet in renal disease; NYHA ¼ New York Heart Association class.
4 Ann Thorac Surg CACERES ET AL 213;95: SURVIVAL AND QOL FOR NONAGENARIANS AFTER CARDIAC SURGERY Table 3. Multivariable Analysis; Final Stepwise Selection Model Variable Hazard Ratio Confidence Interval p Value Age per year Prior surgery Cerebrovascular accident early and long-term outcomes, quality of life data, and a risk model of long-term survival. Lichtman and colleagues [8], using the Medicare Provider Analysis and Report (MedPAR) file, analyzed the trends and outcomes of 4,224 nonagenarian patients undergoing CABG. However, administrative databases commonly lack essential clinical information to develop reliable risk models, and although this is the largest registry-based report in the literature, it did not provide a short- or long-term risk-analysis. There are only 2 studies reporting a multivariable risk model of operative mortality [9, 1] and only 1 focusing on long-term survival in nonagenarians [11]. Speziale and colleagues [9] reported a case series of 127 patients from 8 institutions and concluded that nonelective surgery and preoperative myocardial infarction were associated with a higher operative risk [9]. Bridges and colleagues [1] reported an operative risk model based on the Society of Thoracic Surgeons (STS) cardiac surgical database and identified emergency or salvage clinical status, intraaortic balloon pump use, renal failure, peripheral vascular and cerebrovascular disease, and mitral regurgitation to be associated with an increased operative mortality. A classification tree was reported in this study and showed that 57% of nonagenarians did not present any of these risk factors, showing an operative mortality of 7.2%; an acceptable outcome considering the higher risk of this patient category [1]. Ullery and colleagues [11] reported a risk model of long-term survival on 49 nonagenarians, identifying chronic renal insufficiency, peripheral vascular disease, and a low EF as predictors of decreased survival. In our study, with a much larger study sample, we identified age, cerebrovascular disease, and prior surgery to be associated to a decreased survival. The operative mortality in our study was 13.6%, ranging from 8.8% for CABG-only to 18.9% for CABGvalve. The operative mortality of cardiac surgery in nonagenarians has ranged from 7.1% to 23.5% in previous publications, though most of the studies were centered in the 7% to 13% range [3, 8 17]. The STS database has the largest repository of clinical information on cardiac surgery and reports an operative mortality rate of 11.8% for CABG, 11.4% for valve-only, and 12.% for CABGvalve [1]. Although there has always been a trend for CABG-valve to have a higher operative mortality, similar to our findings none of the previous studies have reported a statistically significant difference among surgical groups; ie, CABG-only, valve-only, and CABGvalve [9, 11]. 161 Unlike younger age groups and the collective population undergoing cardiac surgery, in which women represent 27% of the cases [18], previous publications of cardiac surgery in nonagenarians and our study have consistently found a higher proportion of women, ranging from 33% to 65% [3, 12, 15, 16]. This finding is likely related to the longer life expectancy in women, which is over 5 years longer compared with men [19]. The 1- and 5-year survival rates in our series were 71.8% and 37.1%, respectively; rates consistent with previous publications that report 1- and 5-year survival rates ranging from 64% to 87% and 26% to 54%, respectively [3, 12, 15, 2]. The median survival in our series was 3.5 years (2.8 years for men and 4.3 years for women), which is in close proximity to the age-matched life expectancies for the US population (3.6 years for men and 4.3 years for women [19]). Easo and colleagues [12] compared the survival of nonagenarians undergoing cardiac surgery (17 patients) with data from life tables, without showing a significant difference; in contrast, Guilfoyle and colleagues [21] conducted a similar comparison (23 patients) and found a standardized mortality ratio of.52 in favor of nonagenarians undergoing cardiac surgery. These studies, although contradictory, included a very limited number of patients, and the results may not be as robust as the data presented in our study. Furthermore, it has to be noted that nonagenarians undergoing cardiac surgery are not representative of the unselected population described in life tables; in fact, the survival of the former is expected to be significantly limited due to their higher comorbidity index. The QOL assessment after cardiac surgery in nonagenarians has been addressed in few studies and has invariably reported favorable results, showing negative effects in very few instances, which is consistent with the 4% decline in QOL reported in our study [3, 11, 17, 21 23]. In 1997 our group presented the early experience of openheart surgery in nonagenarians and showed that 89% of the patients reported an improvement in QOL, while 78% of the survivors were in New York Heart Association class I or II within 2 years of the operation [17]. There is agreement from previous publications that cardiac surgery in the elderly carries an increased operative mortality. Adjusted and unadjusted analyses in this sector of the population have reported an increased operative risk in the setting of an urgent or emergency surgery, and several publications have suggested that a delay in referral to surgical treatment may be in part responsible [9, 2]. Nonetheless, the STS database reports comparable rates of nonelective surgery for CABG (56.1% vs 5.8%), valve-only (36.5% vs 38.7%), and CABG-valve (27.9% vs 23.4%) in nonagenarians and the collective of all age groups, respectively, suggesting that a delay in surgical treatment may not play a significant role [1, 18]. Despite a higher operative risk, there is consistent data from prior publications supporting that nonagenarians undergoing cardiac surgery are highly symptomatic and have significant limitations in survival and QOL, and that pursuing surgical treatment has beneficial long-term ADULT CARDIAC
5 162 CACERES ET AL Ann Thorac Surg SURVIVAL AND QOL FOR NONAGENARIANS AFTER CARDIAC SURGERY 213;95: effects at the expense of an increased but acceptable upfront operative mortality [1, 21, 24]. Limitations Our study shares the inherent weaknesses of any retrospective study. The patients undergoing cardiac surgery represent a highly selected group and the results may not be generalized to all nonagenarians considered for surgical treatment. Neither ours nor previous studies provide a control group for comparison, other than life table survival data from the unselected US population. Similar to previous publications, the QOL assessment was not 1% complete, and missing data may bias the results. Although we present the largest institutional study to date, the limited patient samples of our and previous studies limit the number of variables to be entered in a multivariable analysis. Despite the various limitations noted, our data present favorable results and support a strong consideration for the risks and benefits of cardiac surgery in this sector of the population. Conclusions The elderly population is rapidly expanding and cardiac surgery in nonagenarians has significantly increased in the last 2 decades, with a higher representation of women as compared with younger age groups. Although risk stratification modeling may be limited by small patient samples, our and previous reports do not support gender and type of surgery as significant risk factors, as opposed to younger age groups. Conversely, age, prior cerebrovascular accident, and prior cardiac surgery appear to be associated with a decreased long-term survival. Cardiac surgery in nonagenarians is a valid option with an increased but not prohibitive operative mortality; however, offset by favorable results in long-term survival and QOL. Proper patient selection with a heightened attention to the functional reserve and the expectation for a QOL improvement is paramount to ensure the most favorable outcomes. References 1. Available at projections/summarytables.html. Accessed on September 25th, Ohlow MA, Hassan A, Lotze U, Lauer B. Cardiac catheter isation in nonagenarians: single center experience. J Geriatr Cardiol 212;9: Jonsson A, Agnarsson BA, Hallgrímsson J. Coronary atherosclerosis and myocardial infarction in nonagenarians: a retrospective autopsy study. Age Ageing 1985;14: Vasques F, Messori A, Lucenteforte E, Biancari F. Immediate and late outcome of patients aged 8 years and older undergoing isolated aortic valve replacement: a systematic review and meta analysis of 48 studies. Am Heart J 212;163: Stoica SC, Cafferty F, Kitcat J, et al. Octogenarians under going cardiac surgery outlive their peers: a case for early referral. Heart 26;92: Edmunds LH Jr, Stephenson LW, Edie RN, Ratcliffe MB. Open heart surgery in octogenarians. N Engl J Med 1988;319: Rich MW, Sandza JG, Kleiger RE, Connors JP. Cardiac operations in patients over 8 years of age. J Thorac Car diovasc Surg 1985;9: Lichtman JH, Kapoor R, Wang Y, Radford MJ, Allen NB, Krumholz HM. Temporal trends of outcomes for nonage narians undergoing coronary artery bypass grafting, 1993 to Am J Cardiol 27;1: Speziale G, Nasso G, Barattoni MC, et al. Operative and middle term results of cardiac surgery in nonagenarians: a bridge toward routine practice. Circulation 21;121: Bridges CR, Edwards FH, Peterson ED, Coombs LP, Ferguson TB. Cardiac surgery in nonagenarians and cente narians. J Am Coll Surg 23;197: Ullery BW, Peterson JC, Milla F, et al. Cardiac surgery in select nonagenarians: should we or shouldn t we? Ann Thorac Surg 28;85: Easo J, Holzl PP, Horst M, Dikov V, Litmathe J, Dapunt O. Cardiac surgery in nonagenarians: pushing the boundary one further decade. Arch Gerontol Geriatr 211;53: Bacchetta MD, Ko W, Girardi LN, et al. Outcomes of cardiac surgery in nonagenarians: a 1 year experience. Ann Thorac Surg 23;: Samuels LE, Sharma S, Morris RJ, et al. Cardiac surgery in nonagenarians. J Card Surg 1996;11: Hovanesyan A, Moon MR, Rich MW. Cardiac surgery in nonagenarians. J Cardiovasc Surg (Torino) 27;48: Roberts WC, Ko JM, Matter GJ. Aortic valve replacement for aortic stenosis in nonagenarians. Am J Cardiol 26;98: Blanche C, Matloff JM, Denton TA, et al. Cardiac operations in patients 9 years of age and older. Ann Thorac Surg 1997;63: Shahian DM, O Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 28 cardiac surgery risk models: part 1 coronary artery bypass grafting surgery. Ann Thorac Surg 29;88(1 Suppl):S Available at nvsr59 9.pdf. Accessed on September 25, Speziale G, Nasso G, Barattoni MC, et al. Short term and long term results of cardiac surgery in elderly and very elderly patients. J Thorac Cardiovasc Surg 211;141: Guilfoyle MR, Drain AJ, Khan A, Ferguson J, Large SR, Nashef SA. Cardiac surgery in nonagenarians: single centre series and review. Gerontology 21;56: Levy Praschker BG, Leprince P, Bonnet N, et al. Cardiac surgery in nonagenarians: hospital mortality and long term follow up. Interact Cardiovasc Thorac Surg 26;5: Miller DJ, Samuels LE, Kaufman MS, Morris RJ, Thomas MP, Brockman SK. Coronary artery bypass surgery in nonage narians. Angiology 1999;5: Edwards MB, Taylor KM. Outcomes in nonagenarians after heart valve replacement operation. Ann Thorac Surg 23;: 83 4.
Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction
Aortic Valve Replacement or Heart Transplantation in Patients With Aortic Stenosis and Severe Left Ventricular Dysfunction L.S.C. Czer, S. Goland, H.J. Soukiasian, S. Gallagher, M.A. De Robertis, J. Mirocha,
More informationSupplementary Online Content
1 Supplementary Online Content Friedman DJ, Piccini JP, Wang T, et al. Association between left atrial appendage occlusion and readmission for thromboembolism among patients with atrial fibrillation undergoing
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al. Comparative
More informationAcquired Cardiovascular Disease
Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National Database James M. Brown,
More informationTechnical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005
Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 The Pennsylvania Health Care Cost Containment Council April 2007 Preface This document serves as a technical supplement to
More informationMitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation
Mitral Gradients and Frequency of Recurrence of Mitral Regurgitation After Ring Annuloplasty for Ischemic Mitral Regurgitation Matthew L. Williams, MD, Mani A. Daneshmand, MD, James G. Jollis, MD, John
More informationValve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal
Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection
More informationBicuspid aortic root spared during ascending aorta surgery: an update of long-term results
Short Communication Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results Marco Russo, Guglielmo Saitto, Paolo Nardi, Fabio Bertoldo, Carlo Bassano, Antonio Scafuri,
More informationOn-Pump vs. Off-Pump CABG: The Controversy Continues. Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery
On-Pump vs. Off-Pump CABG: The Controversy Continues Miguel Sousa Uva Immediate Past President European Association for Cardiothoracic Surgery On-pump vs. Off-Pump CABG: The Controversy Continues Conflict
More informationImpaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events
Diabetes Care Publish Ahead of Print, published online May 28, 2008 Chronotropic response in patients with diabetes Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts
More informationMitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia
Mitral Valve Repair Does Hospital Volume Matter? Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Bogotá Colombia Disclosures Edwards Lifesciences Consultant Abbott Mitraclip Royalties
More informationDoes Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement?
Original Article Does Patient-Prosthesis Mismatch Affect Long-term Results after Mitral Valve Replacement? Hiroaki Sakamoto, MD, PhD, and Yasunori Watanabe, MD, PhD Background: Recently, some articles
More informationRisk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery
Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen
More informationThe Second Best Arterial Graft:
The Second Best Arterial Graft: A Propensity Analysis of the Radial Artery Versus the Right Internal Thoracic Artery to Bypass the Circumflex Coronary Artery American Association for Thoracic Surgery,
More informationDecreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England
ORIGINAL ARTICLES: CARDIOVASCULAR Decreasing Mortality for Aortic and Mitral Valve Surgery In Northern New England Nancy J. O. Birkmeyer, PhD, Charles A. S. Marrin, MBBS, Jeremy R. Morton, MD, Bruce J.
More informationContemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology
Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology Damien J. LaPar, MD, MSc, Daniel P. Mulloy, MD, Ivan K. Crosby, MBBS, D. Scott Lim, MD,
More informationClinical Outcome in Patients with Aortic Stenosis
Clinical Outcome in Patients with Aortic Stenosis Is the Prognosis Worse in Patients with Low-Gradient Severe Aortic Stenosis? Yoel Angel BSc, Shemy Carasso MD, Diab Mutlak MD, Jonathan Lessick MD Dsc,
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationThe Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models
The Society of Thoracic Surgeons: 30-Day Operative Mortality and Morbidity Risk Models A. Laurie W. Shroyer, PhD, Laura P. Coombs, PhD, Eric D. Peterson, MD, Mary C. Eiken, MSN, Elizabeth R. DeLong, PhD,
More informationEarly readmission for congestive heart failure predicts late mortality after cardiac surgery
Lee et al Perioperative Management Early readmission for congestive heart failure predicts late mortality after cardiac surgery Richard Lee, MD, MBA, Natalie Homer, BS, Adin-Cristian Andrei, PhD, Edwin
More informationClinical material and methods. Copyright by ICR Publishers 2007
16847_JHVD_Biancari_3197_(116-121)_r1:Layout 1 21/3/07 17:07 Page 116 Predicting Immediate and Late Outcome after Surgery for Mitral Valve Regurgitation with EuroSCORE Jouni Heikkinen, Fausto Biancari,
More informationChapter 2: Identification and Care of Patients With Chronic Kidney Disease
Chapter 2: Identification and Care of Patients With Chronic Kidney Disease Introduction The examination of care in patients with chronic kidney disease (CKD) is a significant challenge, as most large datasets
More informationSafety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement
Safety of Same-Day Coronary Angiography in Patients Undergoing Elective Aortic Valve Replacement Kevin L. Greason, MD, Lars Englberger, MD, Rakesh M. Suri, MD, PhD, Soon J. Park, MD, Charanjit S. Rihal,
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More informationOutcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk
ACQUIRED CARDIOVASCULAR DISEASE Outcomes of off-pump versus on-pump coronary artery bypass grafting: Impact of preoperative risk Marek Polomsky, MD, a Xia He, MS, b Sean M. O Brien, PhD, b and John D.
More informationDoes preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting?
Ad et al Acquired Cardiovascular Disease Does preoperative atrial fibrillation increase the risk for mortality and morbidity after coronary artery bypass grafting? Niv Ad, MD, a Scott D. Barnett, PhD,
More informationSevere left ventricular dysfunction and valvular heart disease: should we operate?
Severe left ventricular dysfunction and valvular heart disease: should we operate? Laurie SOULAT DUFOUR Hôpital Saint Antoine Service de cardiologie Pr A. COHEN JESFC 16 janvier 2016 Disclosure : No conflict
More informationImportance of the third arterial graft in multiple arterial grafting strategies
Research Highlight Importance of the third arterial graft in multiple arterial grafting strategies David Glineur Department of Cardiovascular Surgery, Cliniques St Luc, Bouge and the Department of Cardiovascular
More informationValvular Intervention
Valvular Intervention Outline Introduction Aortic Stenosis Mitral Regurgitation Conclusion Calcific Aortic Stenosis Deformed Eccentric Calcified Nodular Rigid HOSTILE TARGET difficult to displace prone
More informationOutcomes of cardiac surgery in Indigenous Australians
Outcomes of cardiac surgery in Australians Sam J Lehman, Robert A Baker, Philip E Aylward, John L Knight and Derek P Chew Cardiovascular disease is more prevalent among Australians than non- Australians,
More informationReoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment
Reoperation for Bioprosthetic Mitral Structural Failure: Risk Assessment W.R.E. Jamieson, MD; L.H. Burr, MD; R.T. Miyagishima, MD; M.T. Janusz, MD; G.J. Fradet, MD; S.V. Lichtenstein, MD; H. Ling, MD Background
More informationMeasuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France
Measuring the risk in valve patients Lessons learnt from the TAVI story? Bernard Iung Bichat Hospital, Paris, France Faculty disclosure Bernard Iung I disclose the following financial relationships: Consultant
More informationEuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients
c 2009 Wiley Periodicals, Inc. 637 EuroSCORE Predicts Short- and Mid-Term Mortality in Combined Aortic Valve Replacement and Coronary Artery Bypass Patients Kimiyoshi J. Kobayashi, B.S., Jason A. Williams,
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationDepartment of Cardiothoracic Surgery, Heart and Lung Center, Lund University Hospital, Lund, Sweden
Long-Term Outcome of the Mitroflow Pericardial Bioprosthesis in the Elderly after Aortic Valve Replacement Johan Sjögren, Tomas Gudbjartsson, Lars I. Thulin Department of Cardiothoracic Surgery, Heart
More informationIschemic Mitral Valve Disease: Repair, Replace or Ignore?
Ischemic Mitral Valve Disease: Repair, Replace or Ignore? Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil DISCLOSURE I have no financial relationship
More informationSupplementary Online Content
Supplementary Online Content Inohara T, Manandhar P, Kosinski A, et al. Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter
More informationLow ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients
Low ALT Levels Independently Associated with 22-Year All-Cause Mortality Among Coronary Heart Disease Patients N. Peltz-Sinvani, MD 1,4,R.Klempfner,MD 2,4, E. Ramaty, MD 1,4,B.A.Sela,PhD 3,4,I.Goldenberg,MD
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationSupplementary Online Content
Supplementary Online Content Leibowitz M, Karpati T, Cohen-Stavi CJ, et al. Association between achieved low-density lipoprotein levels and major adverse cardiac events in patients with stable ischemic
More informationRevascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease
Impact of Angiographic Complete Revascularization after Drug-Eluting Stent Implantation or Coronary Artery Bypass Surgery for Multivessel Coronary Disease Young-Hak Kim, Duk-Woo Park, Jong-Young Lee, Won-Jang
More informationRisk of Not Being Discharged Home After Isolated Coronary Artery Bypass Graft Operations
Risk of Not Being Discharged Home After Isolated Coronary Artery Bypass Graft Operations James Edgerton, MD, Giovanni Filardo, PhD, MPH, William H. Ryan, MD, William T. Brinkman, MD, Robert L. Smith, MD,
More informationUSRDS UNITED STATES RENAL DATA SYSTEM
USRDS UNITED STATES RENAL DATA SYSTEM Chapter 2: Identification and Care of Patients With CKD Over half of patients from the Medicare 5 percent sample have either a diagnosis of chronic kidney disease
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set
More informationCoronary artery bypass grafting (CABG) is one of the most intensely scrutinized
Surgery for Acquired Cardiovascular Disease Novick et al Direct comparison of risk-adjusted and non risk-adjusted CUSUM analyses of coronary artery bypass surgery outcomes Richard J. Novick, MD, a Stephanie
More informationA Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty
JACC Vol. 33, No. 1 January 1999:63 72 63 INTERVENTIONAL CARDIOLOGY A Comparison of Three-Year Survival After Coronary Artery Bypass Graft Surgery and Percutaneous Transluminal Coronary Angioplasty EDWARD
More informationNew-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery
New-Onset Postoperative Atrial Fibrillation and Long-Term Survival After Aortic Valve Replacement Surgery Giovanni Filardo, PhD, MPH, Cody Hamilton, PhD, Baron Hamman, MD, Robert F. Hebeler, Jr, MD, John
More informationLong-term results (22 years) of the Ross Operation a single institutional experience
Long-term results (22 years) of the Ross Operation a single institutional experience Authors: Costa FDA, Schnorr GM, Veloso M,Calixto A, Colatusso D, Balbi EM, Torres R, Ferreira ADA, Colatusso C Department
More informationQuestions are frequently raised regarding aggressive
Late Outcomes of Open Heart Surgery in Patients 70 Years or Older Jamal H. Khan, MD, Sandra Magnetti, DrPH, Elaine Davis, EdD, and Jianliang Zhang, PhD Charleston Area Medical Center, West Virginia University,
More informationJournal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL
More informationRespiratory failure (RF), or prolonged mechanical ventilation,
CARDIOTHORACIC ANESTHESIOLOGY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationIncidence, Predictors, and Outcomes of Prosthesis-Patient Mismatch in 62,125 TAVR Patients. An STS/ACC TVT Registry Report
Incidence, Predictors, and Outcomes of Prosthesis-Patient Mismatch in 62,125 TAVR Patients An STS/ACC TVT Registry Report Howard C. Herrmann, MD University of Pennsylvania Philadelphia Howard C. Herrmann
More informationPolicy Specific Section: March 30, 2012 March 7, 2013
Medical Policy Transcatheter Aortic Valve Replacement for Aortic Stenosis Type: Medical Necessity and Investigational / Experimental Policy Specific Section: Surgery Original Policy Date: Effective Date:
More informationAtrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database
Atrial Fibrillation Correction Surgery: Lessons From The Society of Thoracic Surgeons National Cardiac Database James S. Gammie, MD, Michel Haddad, MD, Sarah Milford-Beland, MS, Karl F. Welke, MD, T. Bruce
More informationThe operative mortality rate after redo valvular operations
Clinical Outcomes of Redo Valvular Operations: A 20-Year Experience Naoto Fukunaga, MD, Yukikatsu Okada, MD, Yasunobu Konishi, MD, Takashi Murashita, MD, Mitsuru Yuzaki, MD, Yu Shomura, MD, Hiroshi Fujiwara,
More informationTransfusion and Blood Stream Infections after Coronary Surgery
1 Transfusion and Blood Stream Infections after Coronary Surgery Tuomas Tauriainen, a Eeva-Maija Kinnunen, a Idamaria Laitinen, a Vesa Anttila, b Tuomas Kiviniemi, b Juhani K.E. Airaksinen, b and Fausto
More informationRelationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome
Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João
More informationIschemic Ventricular Septal Rupture
Ischemic Ventricular Septal Rupture Optimal Management Strategies Juan P. Umaña, M.D. Chief Medical Officer FCI Institute of Cardiology Disclosures Abbott Mitraclip Royalties Johnson & Johnson Proctor
More informationParsimonious assessment for reoperative aortic valve replacement; the deterrent effect of low left ventricular ejection fraction and renal impairment
Featured Article Parsimonious assessment for reoperative aortic valve replacement; the deterrent effect of low left ventricular ejection fraction and renal impairment Maroun Yammine*, Fernando Ramirez-Del
More informationThe Who, How and When of Advanced Heart Failure Therapies. Disclosures. What is Advanced Heart Failure?
The Who, How and When of Advanced Heart Failure Therapies 9 th Annual Dartmouth Conference on Advances in Heart Failure Therapies Dartmouth-Hitchcock Medical Center Lebanon, NH May 20, 2013 Joseph G. Rogers,
More informationery: Comparison of Predicted and Observed Resu ts
Preoperative Risk Assessment in Cardiac Sur K ery: Comparison of Predicted and Observed Resu ts Forrest L. Junod, M.D., Bradley J. Harlan, M.D., Janie Payne, R.N., Edward A. Smeloff, M.D., George E. Miller,
More informationJournal of the American College of Cardiology Vol. 35, No. 3, by the American College of Cardiology ISSN /00/$20.
Journal of the American College of Cardiology Vol. 35, No. 3, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00608-7 The Prognostic
More informationThe European System for Cardiac Operative Risk. Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery
Validation of EuroSCORE II in Patients Undergoing Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Francesco Vasques, MS, Reija Mikkola, MS, Marta Martin, MS, Jarmo Lahtinen, MD, PhD, and Jouni
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationLucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*
Cea Soriano et al. Cardiovascular Diabetology (2015) 14:38 DOI 10.1186/s12933-015-0204-5 CARDIO VASCULAR DIABETOLOGY ORIGINAL INVESTIGATION Open Access Cardiovascular events and all-cause mortality in
More information10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice
10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia
More informationPercutaneous Mitral Valve Repair
Percutaneous Mitral Valve Repair MitraClip: Procedure, Data, Patient Selection Chad Rammohan, MD FACC Director, Cardiac Cath Lab El Camino Hospital Mountain View, California Mitral Regurgitation MitraClip
More informationPREDICTORS OF PROLONGED HOSPITAL STAY
PREDICTORS OF PROLONGED HOSPITAL STAY IN CARDIAC SURGERY Zuraida Khairudin Faculty of Science Computer and Mathematics, Universiti Teknologi MARA, Malaysia zurai405@salam.uitm.edu.my ABSTRACT quality of
More informationTAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con
TAVR 2018: TAVR has high clinical efficacy according to baseline patient risk! ii. Con Dimitrios C. Angouras, MD, FETCS Associate Professor of Cardiac Surgery National and Kapodistrian University of Athens,
More informationAttendance rates and outcomes of cardiac rehabilitation in Victoria, 1998
Attendance rates and outcomes of cardiac rehabilitation in Victoria, 1998 CARDIOVASCULAR DISEASE is the leading cause of death in Australia, causing more than 40% of all deaths in 1998. 1 Cardiac rehabilitation
More informationJournal of the American College of Cardiology Vol. 44, No. 9, by the American College of Cardiology Foundation ISSN /04/$30.
Journal of the American College of Cardiology Vol. 44, 9, 2004 2004 by the American College of Cardiology Foundation ISSN 0735-1097/04/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2004.04.062 Relation
More informationOutcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era
Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era Sebastian A. Iturra, Rakesh M. Suri, Kevin L. Greason, John
More informationAortic Stenosis in the Elderly: Difficulties for the Clinician. Are Symptoms Due to Aortic Stenosis?
Aortic Stenosis in the Elderly: Difficulties for the Clinician Are Symptoms Due to Aortic Stenosis? Raphael Rosenhek Department of Cardiology Medical University of Vienna No disclosure European Society
More informationCORONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW
CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN CONARY ARTERY BYPASS GRAFT (CABG) MEASURES GROUP: #43 Coronary Artery Bypass Graft (CABG):
More informationProspective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease
Prospective Evaluation of the Eyeball Test for Assessing Frailty in Elderly Patients with Valvular Heart Disease Background Frailty is a common occurrence in elderly patients Approximately half of the
More informationStrokes After TAVR Reasons for Declining Frequency
Strokes After TAVR Reasons for Declining Frequency Samir Kapadia, MD Professor of Medicine Director, Cardiac Catheterization Laboratory Cleveland Clinic Disclosure NONE Second Generation Valves Newer
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationCIPG Transcatheter Aortic Valve Replacement- When Is Less, More?
CIPG 2013 Transcatheter Aortic Valve Replacement- When Is Less, More? James D. Rossen, M.D. Professor of Medicine and Neurosurgery Director, Cardiac Catheterization Laboratory and Interventional Cardiology
More informationUnprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality
Unprotected Left Main Coronary Artery Disease in Patients With Low Predictive Risk of Mortality Shun Watanabe, MD, Tatsuhiko Komiya, MD, Genichi Sakaguchi, MD, PhD, and Takeshi Shimamoto, MD, PhD Department
More informationCoronary Artery Bypass Surgery in Octogenarians: Long-Term Outcome Can Be Better Than Expected
Coronary Artery Bypass Surgery in s: Long-Term Outcome Can Be Better Than Expected Juha Nissinen, MD, Jan-Ola Wistbacka, MD, PhD, Pertti Loponen, MD, Kari Korpilahti, MD, PhD, Kari Teittinen, MD, Markku
More informationEmergency surgery in acute coronary syndrome
Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
More informationCardiac surgery in Victorian public hospitals, Public report
Cardiac surgery in Victorian public hospitals, 2009 10 Public report Cardiac surgery in Victorian public hospitals, 2009 10 Public report Authors: DT Dinh, L Tran, V Chand, A Newcomb, G Shardey, B Billah
More informationClinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD
Clinical Practice Guidelines and the Under Treatment of Concomitant AF Vinay Badhwar, MD Gordon F. Murray Professor and Chairman Department of Cardiovascular & Thoracic Surgery WVU Heart and Vascular Institute
More informationTwenty Years of Cardiac Surgery in Patients Aged 80 Years and Older: Risks and Benefits
Twenty Years of Cardiac Surgery in Patients Aged 80 Years and Older: Risks and Benefits Markus Krane, MD,* Bernhard Voss, MD,* Andreas Hiebinger, MD, Marcus Andre Deutsch, MD, Michael Wottke, MD, MPH,
More informationPredictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT- Before Cardiac Surgery Sai Polineni, MPH; Devin M. Parker, MS; Shama S. Alam, PhD, MSc; Heather Thiessen-Philbrook, BMath, MMath;
More informationPresenter Disclosure. Patrick O. Myers, M.D. No Relationships to Disclose
Presenter Disclosure Patrick O. Myers, M.D. No Relationships to Disclose Aortic Valve Repair by Cusp Extension for Rheumatic Aortic Insufficiency in Children Long term Results and Impact of Extension Material
More informationIs TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients
Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients Saibal Kar, MD, FACC, FAHA, FSCAI Director of Interventional Cardiac Research Cedars Sinai Heart Institute, Los Angeles, CA Potential
More informationDisclosures The PREVENT IV Trial was supported by Corgentech and Bristol-Myers Squibb
Saphenous Vein Grafts with Multiple Versus Single Distal Targets in Patients Undergoing Coronary Artery Bypass Surgery: One-Year Graft Failure and Five-Year Outcomes from the Project of Ex-vivo Vein Graft
More informationIn the United States, 97 million overweight or obese
The Risks of Moderate and Extreme Obesity for Coronary Artery Bypass Grafting Outcomes: A Study From The Society of Thoracic Surgeons Database Ganga Prabhakar, MD, Constance K. Haan, MD, Eric D. Peterson,
More informationAortic stenosis in octogenarians and comorbidities. Constantinos Evdoridis, MD Elpis General Hospital, Athens
Aortic stenosis in octogenarians and comorbidities Constantinos Evdoridis, MD Elpis General Hospital, Athens Decision to operate according to age range European Heart Journal (2005) 26, 2714 2720 Fitness
More informationCoronary Artery Stenosis. Insight from MAIN-COMPARE Study
PCI for Unprotected Left Main Coronary Artery Stenosis Insight from MAIN-COMPARE Study Young-Hak Kim, MD, PhD Cardiac Center, University of Ulsan College of Medicine, Asan Medical Center Current Practice
More informationMinimally Invasive Mitral Valve Repair: Indications and Approach
Minimally Invasive Mitral Valve Repair: Indications and Approach Juan P. Umaña, M.D. Chief Medical Officer Director, Cardiovascular Medicine FCI - Institute of Cardiology Bogota Colombia 1 Mitral Valve
More informationOPCAB IS NOT BETTER THAN CONVENTIONAL CABG
OPCAB IS NOT BETTER THAN CONVENTIONAL CABG Harold L. Lazar, M.D. Harold L. Lazar, M.D. Professor of Cardiothoracic Surgery Boston Medical Center and the Boston University School of Medicine Boston, MA
More informationBelow is summarised some of the tools and papers that are worth looking at if you have an interest in the area.
What happens to the high risk patients who don t die? Perioperative SIG meeting PBLD Noosa 2015 Nicola Broadbent, Auckland, NZ In the process of writing this problem based learning discussion I have read
More informationFive-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial
Five-Year Outcomes of Transcatheter Aortic Valve Replacement (TAVR) in Inoperable Patients With Severe Aortic Stenosis: The PARTNER Trial Samir R. Kapadia, MD On behalf of The PARTNER Trial Investigators
More informationPeri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)
Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY) Thomas Walther, Christian W. Hamm, Gerhard Schuler, Alexander Berkowitsch,
More informationWhat is the Role of Surgical Repair in 2012
What is the Role of Surgical Repair in 2012 The Long-Term Results of Surgery Raphael Rosenhek Department of Cardiology Medical University of Vienna European Society of Cardiology 2012 Munich, August 27th
More informationVariation in Mortality Risk Factors With Time After Coronary Artery Bypass Graft Operation
CARDIOVASCULAR Variation in Mortality Risk Factors With Time After Coronary Artery Bypass Graft Operation Dexiang Gao, PhD, Gary K. Grunwald, PhD, John S. Rumsfeld, MD, PhD, Todd Mackenzie, PhD, Frederick
More informationIs TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry
Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry E Van Belle, E Teiger, F Juthier, A Vincentelli, B Iung, H Eltchaninoff, J Fajadet,
More information